Outcome measures of phase III anticancer drug trials in China.
Guo L, Huang H, Yu Y, Wang J, Wang L, Wang S, Wu D, Fang Y, Jiang N, Zhang S, Tang Y, Li N.
Guo L, et al. Among authors: wang l, wang j, wang s.
Chin Med J (Engl). 2023 Apr 20;136(8):992-994. doi: 10.1097/CM9.0000000000002264. Epub 2023 Apr 7.
Chin Med J (Engl). 2023.
PMID: 37026851
Free PMC article.
No abstract available.